Skip to main content

Table 2 Comparison of ADC values between groups

From: Apparent diffusion coefficient value of brain metastasis from lung carcinoma as potential predictor of epidermal growth factor receptor mutation

Patients’ Group

ROI 1 (10−3 mm2/s)

ROI 2 (10−3 mm2/s)

ROI 3 (10−3 mm2/s)

ADClesion Mean (10−3 mm2/s)

ADCmin Mean (10−3 mm2/s)

ADC NL

Mean

ADClesion/ ADC NL Ratio (%)

EGFR Mutation

0.79 ± 0.24

0.82 ± 0.26

0.82 ± 0.26

*0.81 ± 0.25

0.76 ± 0.24

0.87

94

Non-EGFR mutation

0.8 ± 0.21

0.83 ± 0.23

0.83 ± 0.26

0.82 ± 0.23

0.76 ± 0.21

0.92

94

    

p = 0.956

p = 0.985

  

The mean of ADC value of non-lesion sites

   

*0.89 ± 0.21

   
    

*p = 0.636

   
  1. ROI Region of interest, ADC Apparent diffusion coefficient, EGFR Epidermal growth factor receptor, NL Non lesion
  2. *p The p value that comparing mean of ADC in EGFR mutation group and in non-lesion